Dr. Devang M. Padalia, MD

Dr. Padalia practices at Pain & Wellness Institute in Tampa, Florida.

Dr. Padalia's NPI, 1346238748, was assigned on October 10, 2005. Dr. Padalia graduated from University Of Florida College Of Medicine in 2001. Dr. Padalia holds Florida license ME93557.

Dr. Padalia's primary practice is Pain & Wellness Institute, at 4509 N Armenia Ave, Tampa, FL 33603. The practice phone is (813) 873-7777.

Dr. Padalia's primary practice is Pain & Wellness Institute in Tampa, Florida. The medical group on file is Pain & Wellness Institute. Dmand AI also links Dr. Padalia to 1 more group practice or clinic, named with a free account. Dr. Padalia's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Padalia practices, 2 sites in all. Vendor and product names are available with a free account.

Pain medicine is Dr. Padalia's primary specialty in the NPI Registry, under taxonomy code 207LP2900X. Dr. Padalia is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Padalia's licenses on file in 2 states: Florida and Connecticut.

Dmand AI lists back pain injection, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal stenosis and thoracic spine disorders among the conditions Dr. Padalia treats.

CMS data shows 1,273 Medicare services from Dr. Padalia across 16 procedure codes in 2024, for 145 Medicare patients. Medicare paid $129,240 for them. Every service was in an office.

CMS counts 145 Medicare patients who saw Dr. Padalia in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have arthritis, and 75% have high blood pressure. 42% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Padalia's median patient age at 69, with 59% women.

In 2024, Dr. Padalia wrote 11,781 Medicare Part D claims for 1,057 patients. 99% of them were for generic drugs. CMS names the drug for 11,709 of them, across 26 drugs with 11 or more claims each, at $228,072 in total drug cost. In 2023, CMS named 9,101 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Padalia for performance year 2024, reported individually. Dr. Padalia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Padalia, published from 2016 to 2021. 2016 was the busiest year, with 3. The most frequent topics are Electrodes, Implanted, Infusion Pumps, Implantable and Injections, Spinal. Dr. Padalia has published most often in A A Pract. Dr. Padalia's most frequent co-authors are Corey Joseph Reeves, MD, Enrique Galang, MD and Navdeep Singh Jassal, MD.

CMS Open Payments shows 127 general payments to Dr. Padalia from 19 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 61% of the total. Medtronic USA, Inc. paid the most, $14,962.

Dr. Padalia graduated from University Of Florida College Of Medicine in 2001.

Dr. Padalia is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.